Masimo announced U.S. Food and Drug Administration 510(k) clearance for the Root patient monitoring and connectivity platform. The platform includes a built-in connectivity gateway through Iris for ...
LiDCO Offers Clinicians, for the First Time, a Board-in-Cable Solution Designed to Provide a More Complete Picture of Oxygen Delivery NEUCHATEL, Switzerland--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the limited market release of Visual Clinical Activity Monitoring (VCAM™), a video analysis system that uses artificial ...
Now Available for Both Cerebral and Somatic Applications and for All Patient Populations, O3’s Delta Hemoglobin Parameters Offer Clinicians Additional Insight Into Changes in Tissue Oxygen Saturation ...
St. Luke’s University Health Network is marking a decade of leadership and transformation in patient safety through its ...
Masimo Corporation MASI recently announced the findings of a prospective, single-blinded, randomized controlled study in which researchers sought to assess the impact of varying ventilation strategies ...
Earlier this week medical device maker Masimo and Thermomedics, a Positive ID company, launched their new contactless, Bluetooth-enabled thermometer in the US market. The thermometer, called TIR-1, ...
Philips and Masimo are renewing their yearslong collaboration in patient monitoring with what they describe as an expanded focus on developing next-generation vital sign readers, plus a plan to work ...
Amsterdam, the Netherlands and Irvine, California, U.S. – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Masimo (NASDAQ: MASI), a global medical technology company, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results